CRISPR News and Research

RSS
In the late 1980s and mid-1990s, genomes of diverse lineages of bacteria and archaea (the latter representing a domain of single-celled prokaryotic microorganisms) revealed clusters of regularly interspaced short palindromic repeats, known today under the abbreviation CRISPR. Later it was found that these repeat sequences (previously considered disparate) share a common set of features.
Study clears potential obstacle to using gene drive strategy to control mosquitoes

Study clears potential obstacle to using gene drive strategy to control mosquitoes

Diagnostics, Meet CRISPR

Diagnostics, Meet CRISPR

How human cells recognize undesirable guests

How human cells recognize undesirable guests

New genetic techniques expand microbial research

New genetic techniques expand microbial research

Study examines molecular causes of spondylocostal dysostosis

Study examines molecular causes of spondylocostal dysostosis

Primitive bacterial parasites were first to use CRISPR to combat against one another

Primitive bacterial parasites were first to use CRISPR to combat against one another

New CRISPR technology targets thousands of genes

New CRISPR technology targets thousands of genes

Study explains “dark” portion of human genome implicated in various disorders

Study explains “dark” portion of human genome implicated in various disorders

Study reports first-ever application of CRISPR-Cas12b system in plant genome engineering

Study reports first-ever application of CRISPR-Cas12b system in plant genome engineering

Study explores the impact of solute carriers on the activity and potency of cytotoxic drugs

Study explores the impact of solute carriers on the activity and potency of cytotoxic drugs

New chromosome-level detectors developed to monitor cellular activity

New chromosome-level detectors developed to monitor cellular activity

WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway

WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway

A new study finds a potential immunotherapeutic pan-target on cancer cells

A new study finds a potential immunotherapeutic pan-target on cancer cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.